ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | Effects of canagliflozin versus finerenone on cardiorenal outcomes

Effects of canagliflozin versus finerenone on cardiorenal outcomes

Share

https://www.youtube.com/watch?v=eOD4qajQ8EI copy

Other e-seminars from this series

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease

ERA Journal Club

Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease

ERA Journal Club

The association between dual RAAS inhibition and risk of AKI and hyperkalemia in patients with DKD

ERA Journal Club

Women’s representation in clinical trials of patients with chronic kidney disease

ERA Journal Club

Nonsteroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease

ERA Journal Club

Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D

ERA Journal Club

Who killed Bruce Lee? The hyponatraemia hypothesis

ERA Journal Club

Social determinants of health and the transition from advanced chronic kidney disease to kidney failure

ERA Journal Club

Renal artery stenting in the correct patients with atherosclerotic renovascular disease

ERA Journal Club

Impact of kidney transplantation in obese candidates: a time-dependent propensity score matching study

ERA Journal Club

Intravenous sodium thiosulphate treatment for vascular calcification of hemodialysis patients

ERA Journal Club

A prediction model improves the predictive ability for renal replacement therapy

ERA Journal Club